Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Malignant Lymphoma

  Free Subscription


4 Blood
2 Br J Haematol
2 Haematologica
1 J Clin Oncol
2 Leuk Lymphoma
1 Leukemia
1 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. KAWASAKI K, Karube K
    Peripheral T-cell lymphoma with EBV-infected "anaplastic" B-cell proliferation confined to sinuses.
    Blood. 2017;129:1885.
    PubMed     Text format    

    Toward autophagy-targeted therapy in lymphoma.
    Blood. 2017;129:1740-1742.
    PubMed     Text format    

  3. NAYAK L, Iwamoto FM, LaCasce A, Mukundan S, et al
    PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.
    Blood. 2017 Mar 29. pii: blood-2017-01-764209. doi: 10.1182/blood-2017-01-764209
    PubMed     Text format     Abstract available

  4. ENNISHI D, Mottok A, Ben-Neriah S, Shulha HP, et al
    Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell of origin-specific clinical impact.
    Blood. 2017 Mar 28. pii: blood-2016-11-747022. doi: 10.1182/blood-2016-11-747022
    PubMed     Text format     Abstract available

    Br J Haematol

  5. EYRE TA, Osborne WL, Gallop-Evans E, Ardeshna KM, et al
    Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
    Br J Haematol. 2017 Mar 24. doi: 10.1111/bjh.14665.
    PubMed     Text format    

  6. NASTOUPIL LJ, McLaughlin P, Feng L, Neelapu SS, et al
    High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
    Br J Haematol. 2017 Mar 24. doi: 10.1111/bjh.14541.
    PubMed     Text format     Abstract available


  7. DENG AL, Kim YR, Lichtenstein EA, O'Connor OA, et al
    Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B cell lymphoma leg type with mutant MYD88 and wildtype CD79.
    Haematologica. 2017 Mar 24. pii: haematol.2016.161893.
    PubMed     Text format    

  8. FUJI S, Yamaguchi T, Inoue Y, Utsunomiya A, et al
    Development of a modified prognostic index of patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: a possible risk-adapted management strategies including allogeneic transplantation.
    Haematologica. 2017 Mar 24. pii: haematol.2017.164996.
    PubMed     Text format     Abstract available

    J Clin Oncol

  9. ZUCCA E, Conconi A, Martinelli G, Bouabdallah R, et al
    Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.
    J Clin Oncol. 2017 Mar 29:JCO2016706994. doi: 10.1200/JCO.2016.70.6994.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  10. WU SC, Chapman JR, Vega F, Abrahams N, et al
    Hepatosplenic T-cell lymphoma associated with membranoproliferative glomerulonephritis.
    Leuk Lymphoma. 2017 Mar 28:1-4. doi: 10.1080/10428194.2017.1307358.
    PubMed     Text format    

  11. EL CHEIKH J, Massoud R, Haffar B, Fares E, et al
    Bendamustine as a bridge to allogeneic transplant in relapsed/refractory Hodgkin lymphoma patients who failed salvage brentuximab vedotin postautologous peripheral blood stem cell transplantation.
    Leuk Lymphoma. 2017 Mar 28:1-3. doi: 10.1080/10428194.2017.1307362.
    PubMed     Text format    


  12. ATSAVES V, Tsesmetzis N, Chioureas D, Kis L, et al
    PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large cell lymphoma.
    Leukemia. 2017 Mar 27. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

    PLoS One

  13. ZHOU X, Ma T, Zhang Y, Zhou N, et al
    Rituximab maintenance therapy for patients with diffuse large B-cell lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0174648.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  14. CHEN J, Zhang Y, Petrus MN, Xiao W, et al
    Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Proc Natl Acad Sci U S A. 2017 Mar 29. pii: 201700682.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.